ES2110015T3 - Derivados de polisacaridos de heparina, sulfato de heparan, sus fracciones y fragmentos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. - Google Patents

Derivados de polisacaridos de heparina, sulfato de heparan, sus fracciones y fragmentos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2110015T3
ES2110015T3 ES93102527T ES93102527T ES2110015T3 ES 2110015 T3 ES2110015 T3 ES 2110015T3 ES 93102527 T ES93102527 T ES 93102527T ES 93102527 T ES93102527 T ES 93102527T ES 2110015 T3 ES2110015 T3 ES 2110015T3
Authority
ES
Spain
Prior art keywords
heparin
preparation
pharmaceutical compositions
polysaccharides
heparan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93102527T
Other languages
English (en)
Spanish (es)
Inventor
Lino Liverani
Giuseppe Mascellani
Pietro Bianchini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Opocrin SpA
Original Assignee
Opocrin SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opocrin SpA filed Critical Opocrin SpA
Application granted granted Critical
Publication of ES2110015T3 publication Critical patent/ES2110015T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
ES93102527T 1992-02-25 1993-02-18 Derivados de polisacaridos de heparina, sulfato de heparan, sus fracciones y fragmentos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2110015T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920405A IT1254216B (it) 1992-02-25 1992-02-25 Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Publications (1)

Publication Number Publication Date
ES2110015T3 true ES2110015T3 (es) 1998-02-01

Family

ID=11362117

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93102527T Expired - Lifetime ES2110015T3 (es) 1992-02-25 1993-02-18 Derivados de polisacaridos de heparina, sulfato de heparan, sus fracciones y fragmentos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Country Status (5)

Country Link
EP (1) EP0557887B1 (enExample)
AT (1) ATE161273T1 (enExample)
DE (1) DE69315724D1 (enExample)
ES (1) ES2110015T3 (enExample)
IT (1) IT1254216B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668118A (en) * 1992-07-24 1997-09-16 Cavalier Pharmaceuticals Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G
AU688272B2 (en) * 1992-07-24 1998-03-12 Paringenix, Inc. Medicameny for inhibiting neutrophil elastase and cathepsin
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
US6127347A (en) * 1994-01-12 2000-10-03 Univ Michigan Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
US5583121A (en) * 1994-01-12 1996-12-10 Michigan State University Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
US5633233A (en) * 1995-06-07 1997-05-27 Alberta Research Council Modified kojibiosides analogues
WO1997016556A1 (en) 1995-10-30 1997-05-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase i
FR2781485B1 (fr) * 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
WO2000012726A2 (en) 1998-08-27 2000-03-09 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
JP4824170B2 (ja) 1999-04-23 2011-11-30 マサチューセッツ インスティテュート オブ テクノロジー ポリマーを表記するためのシステムおよび方法
EP1266013B1 (en) 2000-03-08 2014-10-15 Massachusetts Institute Of Technology Heparinase iii and uses thereof
PT1319183E (pt) 2000-09-12 2009-06-29 Massachusetts Inst Technology Métodos e produtos relacionados a heparina de baixo peso molecular
WO2002022122A1 (en) * 2000-09-15 2002-03-21 Novo Nordisk A/S Use of compounds for the treatment of obesity
JP2004523479A (ja) 2000-10-18 2004-08-05 マサチューセッツ　インスティテュート　オブ　テクノロジー 多糖の肺送達に関する方法および産物
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
EP2205642B1 (en) 2007-11-02 2016-01-27 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
CN101584688B (zh) * 2008-05-24 2010-11-10 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物
CN101584705B (zh) * 2008-05-24 2010-10-27 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物
CN102985443B (zh) 2010-04-16 2017-05-10 动量制药公司 组织靶向
EP2582355A2 (en) 2010-06-17 2013-04-24 Momenta Pharmaceuticals, Inc. Methods and compositions for promoting hair growth
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2013169355A1 (en) 2012-05-09 2013-11-14 Paringenix, Inc. Treatment of myelosuppression
AU2014274377A1 (en) 2013-05-28 2015-11-12 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
WO2016133910A1 (en) 2015-02-17 2016-08-25 Cantex Pharmaceuticals, Inc. Treatment of cancers and hematopoietic stem cell disorders privileged by cxcl12-cxcr4 interaction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione

Also Published As

Publication number Publication date
EP0557887A3 (enExample) 1994-02-09
EP0557887B1 (en) 1997-12-17
EP0557887A2 (en) 1993-09-01
ATE161273T1 (de) 1998-01-15
ITMI920405A0 (it) 1992-02-25
ITMI920405A1 (it) 1993-08-25
DE69315724D1 (de) 1998-01-29
IT1254216B (it) 1995-09-14

Similar Documents

Publication Publication Date Title
ES2110015T3 (es) Derivados de polisacaridos de heparina, sulfato de heparan, sus fracciones y fragmentos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2059789T3 (es) Esteroides sustituidos con acido fosfinico como inhibidores de la esteroide-5 alfa-reductasa.
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
MX9400175A (es) Derivados de fenil tri-substituidos y proceso para su preparacion.
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
EP0431302A3 (en) Use of curable cycloaliphatic derivatives in putty compositions
MX9206503A (es) Nuevos derivados de lupano, proceso para su preparacion y composicion farmaceutica que los contiene.
FI945434A0 (fi) 4-markatpoasetyyliamino/2/bentsatsepinoni (3) johdannaisia ja niiden käyttö enkefalinaasi-inhibiittoreina
ATE397005T1 (de) Sialyl-lewisa und sialyl-lewisx epitope analoge
ATE136540T1 (de) Analoge von vitamin a und ihre verwendung, insbesondere als cytotrophische und cytoprotective substanzen sowie diese substanzen enthaltende arzneimittel
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
DE69435120D1 (de) Ein Inhibitor für glatte Gefässmuskelzellen für therapeutische Nutzung
ES2167748T3 (es) Derivados del polisacarido k5 con actividad anticoagulante.
ES2063767T3 (es) Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
ECSP941120A (es) Derivados de 1,5 benzodiazepina
AR002017A1 (es) Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento.
PT98779A (pt) Processo para a preparacao de uma composicao anticoagulante contendo inibidor sulfatados e metodos para a sua utilizacao
IT1243987B (it) Procedimento per la preparazione di epossi-eparidi prodotti ottenuti ecomposizioni farmaceutiche che li contengono
PT99435A (pt) Processo para a preparacao de derivados de amino-sulfonil-ureia e de composicoes farmaceuticas que os contem
IL58103A (en) Sila-substituted 1,4-dihydropyridine derivatives,their production and pharmaceutical compositions containing them
NO963497L (no) Fibrin-spesifikt antistoff for anvendelse som et antitrombotisk middel
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
MX9300584A (es) Mezcla de oligosacaridos sulfatados, procedimiento para su preparacion y composicion farmaceutica que la contiene.
ES2058771T3 (es) Preparado combinado con efecto antitrombotico.
ES2099865T3 (es) Ciclopentanoperhidrofenantreno-17beta-(3-furil)-3-derivados y composiciones farmaceuticas que comprenden los mismos para el tratamiento de trastornos cardiovasculares.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 557887

Country of ref document: ES